RaeSedo
Arizona City · Founded 2019
About RaeSedo
RaeSedo generates and optimizes new and improved structural peptidomimetics for the treatment of asthma. Drs. Monica Kraft and Julie Ledford received SSTR funding for a Phase I proposal to develop new, short peptide derivatives and mimetics of the active.
Company Facts
- Founded: 2019
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $3.5M
- Funding stage: Seed
- Last round: Grant (Nov 2022)
- Website: https://raesedoinc.com
- Phone: 6502073480
Industries & Categories
Biotechnology, Health Care, Life Science
Canonical: https://fsome.com/organization/raesedo-2095 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.